Cloud-Clone pitches aldosterone ELISA kit for hormone research

Cloud-Clone is promoting an aldosterone ELISA kit it says is designed to improve research-grade measurement of the steroid hormone across cardiovascular, renal and endocrine studies. The company says the kit reduces cross-reactivity, handles multiple sample types and can support studies of hypertension, kidney disease, heart failure and fibrosis.

Why it matters: - Aldosterone is a key marker in research on hypertension, chronic kidney disease, heart failure, adrenal disorders and organ fibrosis. - Accurate measurement is difficult because the hormone is a small steroid molecule that can be confused with similar compounds and distorted by complex biological samples. - Better quantification can improve mechanistic studies, biomarker work and drug screening across cardiovascular, renal and endocrine research.

What happened: - Cloud-Clone introduced its Aldosterone (ALD) ELISA Kit, Cat. No. CEA911Ge, as a research tool for measuring aldosterone in biological samples. - The company says the kit is designed for use in human, rat, mouse and rabbit research. - The release says the kit is intended for studies tied to RAAS signaling, hypertension, kidney injury, myocardial remodeling, endocrine disease and organ fibrosis.

The details: - Aldosterone is described as the primary human mineralocorticoid that helps regulate sodium-potassium balance, blood volume and blood pressure. - The hormone is synthesized in the adrenal cortex zona glomerulosa and regulated by the renin-angiotensin-aldosterone system. - The release says excess aldosterone contributes to sodium retention, potassium loss, fibrosis, vascular injury and myocardial damage. - Common research samples include serum, plasma, tissue homogenates, cell culture supernatants and urine. - The release says generic ALD ELISA kits often struggle with cross-reactivity, matrix interference and low sensitivity. - Cloud-Clone says its kit uses antibodies developed against aldosterone’s side-chain structure and validated for negligible cross-reactivity with cortisol, oestradiol, progesterone and testosterone. - The kit is said to support a broad linear range and detect subtle aldosterone changes under mild RAAS activation. - The assay is described as compatible with simple dilution instead of extraction or derivatization. - The company says the complete test finishes within three hours. - The kit uses a detachable 96-well microplate and ready-to-use reagents. - The company says the workflow supports batch-to-batch consistency and long-term data comparison.

Between the lines: - The release frames ELISA as the practical middle ground between high-accuracy LC-MS/MS and more limited clinical immunoassay platforms. - Cloud-Clone is positioning the kit for basic-science labs that need higher throughput, lower cost and easier sample handling than mass spectrometry can usually provide. - The message also reflects a broader demand for tools that can measure small shifts in steroid hormones without sacrificing reproducibility.

What's next: - Cloud-Clone says investigators can obtain additional product specifications and technical information through its official global communication channels. - The company says it will continue optimizing detection solutions for hormones, inflammatory mediators and other small-molecule biomarkers. - The kit is being pitched for ongoing work in hypertension mechanisms, renal fibrosis, myocardial remodeling, endocrine research and drug screening.

The bottom line: - Cloud-Clone is betting that a faster, more flexible aldosterone ELISA can help labs get cleaner data from difficult steroid-hormone assays.